BG
ASPX

BlackRock Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BlackRock Group’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,796
Closed -$581K – 3006
2015
Q1 		$581K Buy
+5,796
New +$386K ﹤0.01% 2132
2014
Q3 		– Sell
-971
Closed -$22K – 2923
2014
Q2 		$22K Buy
+971
New +$21.2K ﹤0.01% 2760

BlackRock Group's ASPX Position: Q2 2015 in Review

BlackRock Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 5,796 shares — an estimated $581K sold.

BlackRock Group first reported a position in ASPX in Q2 2014 and held it in 2 quarters. The position peaked at $581K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BlackRock Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Group sold 5,796 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $581K.
  • BlackRock Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • BlackRock Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $581K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.